Who are STW 5-II's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Baracross Tablet, STW5 (Iberogast, BAY98-7411).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/stw-5-ii.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

STW 5-II — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

STW 5-II (STW 5-II) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination product. Area: Gastroenterology.

marketed Herbal combination product Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

STW 5-II (STW 5-II) — Universitaire Ziekenhuizen KU Leuven. STW 5-II is a herbal combination product that modulates gastrointestinal motility and secretion to relieve functional gastrointestinal symptoms.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
STW 5-II TARGET	STW 5-II	Universitaire Ziekenhuizen KU Leuven	marketed	Herbal combination product
Baracross Tablet	Baracross Tablet	Daewoong Pharmaceutical Co. LTD.	marketed	Herbal combination product
STW5 (Iberogast, BAY98-7411)	STW5 (Iberogast, BAY98-7411)	Bayer	phase 3	Herbal combination product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination product class)

Bayer · 1 drug in this class
Daewoong Pharmaceutical Co. LTD. · 1 drug in this class
Universitaire Ziekenhuizen KU Leuven · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). STW 5-II — Competitive Intelligence Brief. https://druglandscape.com/ci/stw-5-ii. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing